Chen, Haizhu
Zhong, Qiaofeng
Zhou, Yu
Qin, Yan
Yang, Jianliang
Liu, Peng
He, Xiaohui
Zhou, Shengyu
Zhang, Changgong
Gui, Lin
Yang, Sheng
Zhou, Liqiang
Shi, Yuankai http://orcid.org/0000-0002-3342-4964
Funding for this research was provided by:
Beijing Natural Science Foundation (H201820659)
China National Major Project for New Drug Innovation (2017ZX09304015)
Article History
Received: 3 January 2022
Accepted: 23 May 2022
First Online: 27 May 2022
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (No. NCC2018JJJ-004). Written informed consent was obtained from all patients.
: Not applicable.
: All the authors declare no conflict of interest.